Clinical Trial Update: A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) [Phase 3]

View source ↗

Summary

A Phase 3 study comparing Travatan (travoprost) to Xalcom over six weeks evaluated safety and efficacy in adults with open-angle glaucoma or ocular hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travatan (travoprost)
• Xalcom

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Status: COMPLETED